MX9306467A - Formulacion novedosa. - Google Patents

Formulacion novedosa.

Info

Publication number
MX9306467A
MX9306467A MX9306467A MX9306467A MX9306467A MX 9306467 A MX9306467 A MX 9306467A MX 9306467 A MX9306467 A MX 9306467A MX 9306467 A MX9306467 A MX 9306467A MX 9306467 A MX9306467 A MX 9306467A
Authority
MX
Mexico
Prior art keywords
novel formulation
vacuum atmosphere
solution
atmosphere
polyoxypropylene
Prior art date
Application number
MX9306467A
Other languages
English (en)
Inventor
Mary Sou
Craig William Davis
Alison Green Floyd
Original Assignee
Wellcome Foudation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foudation Limited filed Critical Wellcome Foudation Limited
Publication of MX9306467A publication Critical patent/MX9306467A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Packages (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un contenedor sellado farmacéuticamente aceptable el cual contiene en una atmósfera al vacío o en una atmósfera al vacío o en una atmósfera inerte una solución inyectable acuosa estéril de un copolímero de bloque de polioxipropileo/polioxietileno, estando la solución substancialmente libre de un antioxidante y estando regulada a un pH de 5.5. a 6.5.
MX9306467A 1992-10-19 1993-10-18 Formulacion novedosa. MX9306467A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929221883A GB9221883D0 (en) 1992-10-19 1992-10-19 Novel formulation

Publications (1)

Publication Number Publication Date
MX9306467A true MX9306467A (es) 1994-05-31

Family

ID=10723654

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9306467A MX9306467A (es) 1992-10-19 1993-10-18 Formulacion novedosa.

Country Status (19)

Country Link
EP (1) EP0671919A1 (es)
JP (1) JPH08502284A (es)
KR (1) KR950703345A (es)
AU (1) AU674895B2 (es)
BR (1) BR9307268A (es)
CA (1) CA2147889A1 (es)
CZ (1) CZ63395A3 (es)
GB (1) GB9221883D0 (es)
HU (1) HUT75701A (es)
IL (1) IL107313A0 (es)
MX (1) MX9306467A (es)
NO (1) NO951462L (es)
NZ (1) NZ256890A (es)
PL (1) PL308459A1 (es)
SI (1) SI9300545A (es)
SK (1) SK44795A3 (es)
TW (1) TW276183B (es)
WO (1) WO1994008596A1 (es)
ZA (1) ZA937714B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009023177A1 (en) * 2007-08-10 2009-02-19 Synthrx, Inc. Polymer therapy for the treatment of chronic microvascular diseases
AU2014337190A1 (en) 2013-10-16 2016-06-02 Liferaft Biosciences, Inc. Diuretic induced alterations of plasma volume
US9757411B2 (en) 2014-07-07 2017-09-12 Aires Pharmaceuticals, Inc. Poloxamer therapy for heart failure
WO2016007537A1 (en) 2014-07-07 2016-01-14 Mast Therapeutics, Inc. A poloxamer composition free of long circulating material and methods for production and uses thereof
WO2016007542A1 (en) 2014-07-07 2016-01-14 Mast Therapeutics, Inc. Poloxamer therapy for heart failure
CN109432511A (zh) * 2018-12-29 2019-03-08 常州乐奥医疗科技股份有限公司 一种温敏型水凝胶及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641240A (en) * 1968-09-27 1972-02-08 Wyandotte Chemicals Corp Method for the treatment of an embolus or thrombus
DE3234084A1 (de) * 1982-09-14 1984-03-15 B. Braun Melsungen Ag, 3508 Melsungen Pharmazeutische zubereitungen zur behandlung von unerwuenschten verwachsungen sowie deren verwendung
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
US4938961A (en) * 1989-04-28 1990-07-03 Geoffrey Collins Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia

Also Published As

Publication number Publication date
HU9501104D0 (en) 1995-06-28
BR9307268A (pt) 1999-05-11
TW276183B (es) 1996-05-21
ZA937714B (en) 1995-04-18
AU5284293A (en) 1994-05-09
HUT75701A (en) 1997-05-28
IL107313A0 (en) 1994-01-25
SK44795A3 (en) 1996-05-08
KR950703345A (ko) 1995-09-20
CA2147889A1 (en) 1994-04-28
JPH08502284A (ja) 1996-03-12
SI9300545A (en) 1994-06-30
EP0671919A1 (en) 1995-09-20
NO951462L (no) 1995-06-13
PL308459A1 (en) 1995-07-24
GB9221883D0 (en) 1992-12-02
CZ63395A3 (en) 1995-07-12
AU674895B2 (en) 1997-01-16
NZ256890A (en) 1995-10-26
WO1994008596A1 (en) 1994-04-28
NO951462D0 (no) 1995-04-18

Similar Documents

Publication Publication Date Title
AU554402B2 (en) Double sterile package
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
ES2098029T3 (es) Vacunas de hepatitis que contienen monofosforil lipido a 3-o-desacilado.
IT1232243B (it) Composizioni farmaceutiche a base di ciclosporine
DE59310197D1 (de) Lagerstabile wässrige pharmazeutische zubereitungen von g-csf
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
AU3855297A (en) Pharmaceutical composition for treating papillomavirus tumours and infection
NZ511085A (en) Oral pharmaceutical compositions containing buprenorphin
TW327602B (en) A pharmaceutical composition of an ophthalmic suspension containing difluprednate
AU625083B2 (en) Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)- en-20-yn-3-one
KR910021375A (ko) 4-(디-n-프로필)아미노-6-아미노카보닐-1,3,4,5-테트라하이드로벤즈[cd]인돌의 결정형 염
MX9306467A (es) Formulacion novedosa.
AU4434189A (en) An anti-human immunodeficiency virus composition
ZA898440B (en) Lactamimides in the treatment of drug-resistant protozoal infections
AU8332791A (en) Oral pharmaceutical compositions containing melatonin
DK0517160T3 (da) Oftalmiske præparater med forlænget frigivelse
ATE191341T1 (de) Tabletten mit thioctsäure bestimmter korngrösse
AU674379B2 (en) Antitussive
IT1260469B (it) Macchina inscatolatrice per fiale in particolare del tipo in vetro ad uso medico
GR3024648T3 (en) Pharmaceutical preparation
NZ333656A (en) Liquid formulation comprising less 5% w/w saturated polyglycosylated C8-10 glycerides (capryl caproyl macrogol glycerides) and a non-peptide for oro-mucosal administration
YU65493A (sh) Novi preparat blok kopolimera
NZ236888A (en) Antibiotic deoxymulundocandin, preparation from aspergillus sydowii culture
ATE126064T1 (de) Arzneizusammensetzungen zur rektalen verabreichung enthaltend gefriergetrocknetes calcitonin.
TH14725EX (th) สารสูตรผสมชนิดใหม่